SHILPA MEDICARE
|
|
BOM : 530549     NSE : SHILPAMED     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 24,2022 |
Price(EOD): ₹ 407.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 3,534.93 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SHILPA MEDICARE | 0.1% | -5.9% | -24.5% |
SUN PHARMACEUTICAL INDUSTRIES | 2.4% | -8.5% | 23.8% |
DIVIS LABORATORIES | 4.3% | 6.7% | -12.6% |
DR REDDYS LABORATORIES | 3.8% | 0% | -18.7% |
CIPLA | 0.8% | -3.2% | -2.4% |
GLAND PHARMA | 2.4% | -7.3% | -17.9% |
PIRAMAL ENTERPRISES | 3.9% | -11% | -33.4% |
CADILA HEALTHCARE | 5.7% | -5.1% | -45.1% |
TORRENT PHARMACEUTICALS | 4.1% | -0.9% | -2.5% |
FUNDAMENTAL ANALYSIS OF SHILPA MEDICARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SHILPA MEDICARE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
22.46
P/E Calculated based on EPS of 18.13
[ Mar2021 - Consolidated Results ] 2.25
P/B Calculated based on Book Value of 181.37
[ Mar2021 - Consolidated Results ] 3.09
P/S Calculated based on Revenues of 1145.52 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
78% 32% 38% |
SHARE PRICE MOMENTUM OF SHILPA MEDICARE
SHILPA MEDICARE vs SENSEX
DEBT OF SHILPA MEDICARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.4 0.26 0.15 0.27 |
0.57 0.29 0.16 0.34 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SHILPA MEDICARE
Pledged Promoter Shares |
0.81 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SHILPA MEDICARE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
25.08% 63.52% 137.09% 196.84% |
63.73% 181.35% 441.06% 283.65% |
QtrlyTrend |
8 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
SHILPA MEDICARE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 3.1% | -1.8% | -13% |
S&P BSE 500 | 2.5% | -2% | -1% |
S&P BSE ALLCAP | 2.5% | -2% | -0.8% |
S&P BSE 400 MIDSMALLCAP | 2% | -1.6% | -1.9% |
S&P BSE MIDSMALLCAP | 2% | -1.4% | -2% |
S&P BSE 250 SMALLCAP | 1.8% | -2.5% | -3.9% |
S&P BSE SMALL CAP | 1.6% | -2.4% | -1.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | 2.5% | -2% | -1% |
NIFTY500 MULTICAP 50:25:25 | 2.3% | -2% | -1.3% |
NIFTY MID SMALL400 | 2% | -1.7% | -1.6% |
NIFTY SMALLCAP250 | 1.7% | -2.4% | -3.2% |
You may also like the below Video Courses
FAQ about SHILPA MEDICARE
Is SHILPA MEDICARE good for long term investment?
As on Jun 24,2022, the Fundamentals of SHILPA MEDICARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of SHILPA MEDICARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SHILPA MEDICARE UnderValued or OverValued?
As on Jun 24,2022, SHILPA MEDICARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SHILPA MEDICARE ?
As on Jun 24,2022, the Intrinsic Value of SHILPA MEDICARE is Rs. 295.68 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 228.28
Fair Value [Median EV / Sales Model] : Rs. 307.36
Fair Value [Median Price / Sales Model] : Rs. 295.68
Median Fair Value of SHILPA MEDICARE : Rs. 295.68
Is SHILPA MEDICARE trading at a Premium or Discount?
As on Jun 24,2022, SHILPA MEDICARE is trading at a Premium of 38% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
